Guangdong Fangsheng Ronghua Pharmaceutical

Guangdong Fangsheng Ronghua Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and chemical drugs. As a core subsidiary of Hunan Fangsheng Pharmaceutical, the company focuses heavily on the musculoskeletal and orthopedic therapeutic areas. Its flagship product, the Tenghuang Jianbi Tablet, is a prominent TCM treatment for bone hyperplasia and osteoarthritis in the Chinese market. The company operates a large-scale, GMP-certified manufacturing base in Zhaoqing, Guangdong, capable of producing various oral dosage forms including tablets, capsules, and granules. Fangsheng Ronghua is integral to its parent company's strategy of modernizing TCM and expanding its footprint in the chronic pain management sector.